BridgeMD
New treatment option for Diabetic Peripheral Neuropathy
Official title Combined Effects of INF and OEP in Patients With Diabetic Peripheral Neuropathy
ClinicalTrials.gov ID: NCT07274735
What this study is testing
- What it's testing
- DPN often leads to balance issues, sensory deficits, and chronic pain, which can severely impact daily functioning and independence. INF therapy aims to improve nerve blood flow and alleviate neuropathic symptoms through manual techniques, while the Otago Exercise Program focuses on enhancing strength and balance to reduce fall risk.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 75
You may be able to join if
- Age 50-75years
- Both male and female patients will be included in the study
- Patient with type 2 diabetes mellitus (diagnosed by the physician)
- Patients with a score ≥ 4 on DN4 scale
- Patients have a score on the Timed Up-and-Go (TUG) test of less than 15 s
You likely can't join if
- Patient with presence of any other systemic disease rather than diabetes such as end-stage renal failure, uncontrolled hypertension, severe...
- Patients with documented active alcohol or drug misuse
- Patient with total or partial amputation of lower extremities
- Participants will be also excluded if they were morbidly obese or if pregnant (self-reported)
- Patient with active inflammations or other inflammatory neuropathies including chronic inflammatory demyelinating polyneuropathy, proximal diabetic...
See the full eligibility criteria
- Age 50-75years
- Both male and female patients will be included in the study
- Patient with type 2 diabetes mellitus (diagnosed by the physician)
- Patients with a score ≥ 4 on DN4 scale
- Patients have a score on the Timed Up-and-Go (TUG) test of less than 15 s
- Able to walk at least 10 meters long
- Patient with presence of any other systemic disease rather than diabetes such as end-stage renal failure, uncontrolled hypertension, severe dyslipidemia, chronic liver disease, autoimmune disease, advanced chronic...
- Patients with documented active alcohol or drug misuse
- Patient with total or partial amputation of lower extremities
- Participants will be also excluded if they were morbidly obese or if pregnant (self-reported)
- Patient with active inflammations or other inflammatory neuropathies including chronic inflammatory demyelinating polyneuropathy, proximal diabetic neuropathy, chemotherapy-induced peripheral neuropathy, autonomic...
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.